Hot Investor Mandate: PE Firm Invests Up to $10M in Early to Growth-Stage Therapeutics, Devices, Diagnostics, and Digital Health Companies With India Angle

17 Mar

An India-focused private equity firm makes early-growth investments in several sectors including the life sciences. The firm seeks to invest in Series A or B and generally invest USD 1-10 million per company. The firm  focuses on India-based companies, but it also invests in companies based outside of India as long as they have some presence in India.

In the life sciences, the firm is interested in therapeutics, specialty pharma, medical devices, diagnostics, healthcare IT, and services. The firm prefers products that require relatively shorter clinical trials. For therapeutics, the firm generally invests in products in pre-clinical stage and is indication agnostic, but typically does not consider orphan indications. For medical devices, the firm will consider all classes and generally looks for devices beyond proof-of-concept.

The firm can both lead or act as co-investor in syndicate.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: